 JPMorgan analyst Michael Rehaut upgraded Azek Company Inc NYSE:AZEK to Overweight from Neutral and raised the price target to 56 an upside of 31 from 54. The analyst believes Azeks valuation currently trading at near-record high discounts to Trex Company Inc, does not fully reflect the companys fundamental prospects over the next two years as well as on a longer-term basis. 